cff-version: 1.2.0
abstract: "<p>The purpose of this study was to elucidate the association between circulating 25(OH)D and pancreatic cancer by using a meta-analytic approach. PubMed, Embase, and Wed of Science databases were searched up to August 9, 2022. A random or fixed-effects model was used to estimate the pooled odds ratio (OR), risk ratio (RR), hazard ratio (HR) and their 95% confidence intervals (CIs). A total of 16 studies with 529,917 participants met the inclusion criteria, of which 10 reported incidence and 6 reported mortality. This systematic review and meta-analysis provided a complete and updated overview on the association of circulating 25(OH)D with pancreatic cancer by considering evidence from different study designs.</p>"
authors:
  - family-names: Shen
    given-names: Yajing
  - family-names: Xia
    given-names: Junfen 
  - family-names: Yang
    given-names: Hongwei 
  - family-names: Yi
    given-names: Chuncheng 
  - family-names: Li
    given-names: Tiandong 
  - family-names: Wang
    given-names: Peng
    orcid: "https://orcid.org/0000-0002-9808-8893"
  - family-names: Wang
    given-names: Keyan 
  - family-names: Sun
    given-names: Changqing 
  - family-names: Ye
    given-names: Hua
title: "The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies"
keywords:
version: 1
identifiers:
  - type: doi
    value: 10.4121/ce868f86-68e3-46a1-b6f5-13871ae11d1c.v1
license: CC0
date-released: 2023-05-12